Our team will be attending the 17th ICNMD 2022 in Brussels

Other news
Written By Stine Krag Brunvold

Our team will be attending the 17th International Congress on Neuromuscular Diseases (ICNMD 2022) in Brussels this week from 5-9 July.

Our CEO Thomas Holm Pedersen - along with Senior Scientist Martin Brandhøj Skov - will be on the ground in Belgium meeting with peers and colleagues from the #neuromusculardisease community.

Stine Krag Brunvold
Previous

An active future made possible by the power of science
Next

Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Ulrik